Navigation Links
NGO Files Pre-Grant Opposition Against Anti-HIV Drug, Combivir

A pre-grant opposition has been filed against the anti-HIV drug, Combivir, manufactured by GlaxoSmithKline, a leading pharmaceutical company //. The Manipur Network of Positive People (MNP+) and the Indian Network of People Living with HIV/AIDS have lodged the complaint at the Kolkata patent office.

The drug formulation is a combination of two essential anti-HIV drugs Lamivudine and Zidovudine and is not a new formulation, said a release. The grant of a patent is believed to make the anti-retroviral treatment expensive for patients afflicted with the deadly disease.

'We are objecting to the patenting of Combivir because it is not a new invention but simply the combination of two existing drugs,' said K K Abraham, president, INP+.

A similar opposition was raised regarding patenting anti-cancer drug, Gleevac, manufactured by Novartis. The patent was turned down subsequently as it was found to nothing more than a new form of an old drug.

Combivir is one of the anti-retroviral drugs used by numerous AIDS/HIV organizations, worldwide. A fixed dose combination of the drug is used in several projects targeted at provision of cheap and effective AIDS/HIV treatment to those who cannot afford the same.

In India, more than 5.1 million people are afflicted with AIDS/HIV and a majority of these are solely dependent on the generic drugs provided by the national HIV/AIDS treatment program. The issue of a patent can lead to domination with respect to drug manufacture, thereby restricting the production of effective and affordable drug alternatives.


'"/>




Page: 1

Related medicine news :

1. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
2. Venus Remedies Files 5th International Patent Application
3. AIIMS Official Files Complaint Against Venugopal
4. Glaxo Files Cancer Drug For Approval With FDA
5. Queensland Opposition not happy over hiring consultancy
6. Opposition: Government turned a deaf ear to warnings about dwindling health care services
7. Kleins Third Way Has Tough Opposition
8. Opposition to Compulsory Fortification of Bread with Folic Acid
9. Opposition against Amendments in the Intellectual Property Law
10. Madhya Pradesh Begins Surya Namaskar Amid Muslim Opposition
11. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NGO Files Pre Grant Opposition Against Anti HIV Drug Combivir

(Date:7/29/2015)... ... July 29, 2015 , ... In ... help with the problems of substance abuse that face today’s society, A Forever ... to come to their rehabilitation center. The facility, located in Southwest Michigan hosted ...
(Date:7/29/2015)... ... July 29, 2015 , ... This past week, CARE Surrogacy Center ... a treasured member of the CARE extended family. , By shedding light on ... parents across the globe gain a newfound perspective on surrogacy in Mexico. The center ...
(Date:7/29/2015)... ... July 29, 2015 , ... Abt Associates has named Selena ... division. In her position, Ramkeesoon will help build and expand work in ... spent close to a decade at ICF International, most recently as a vice ...
(Date:7/29/2015)... Boston, MA (PRWEB) , ... July 29, 2015 ... ... nonconforming experience widespread discrimination and health inequities. Since 2012, Massachusetts law has provided ... public education, and business. However, the law does not protect against discrimination based ...
(Date:7/29/2015)... , ... July 29, 2015 , ... " Core Organizer ... look at the latest and coolest applications on the market for iOS, Android, and ... and shared with viewers how this app will help anyone get organized. , Wouldn’t ...
Breaking Medicine News(10 mins):Health News:MADD Victim Services Specialist Visits A Forever Recovery Rehabilitation Facility 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 3Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:Get More Organized with the Core Organizer App 2
... improved planning of care and stronger relationships with physicians ... to a study by a Queen,s University professor. , ... every Canadian," says professor of Medicine and Epidemiology Daren ... Hospital. "But it,s not always happening. We know from ...
... WEDNESDAY, Oct. 27 (HealthDay News) --Mental health issues confronted ... Iraq and Afghanistan differ by gender, new research suggests. ... a diagnosis of depression than are their male counterparts, ... received health care from the Veterans Administration from 2002 ...
... Heidelberg, Germany, 27 October 2010 The European ... of outstanding research contributions by 63 life scientists ... life-long honour of EMBO membership, joining almost 1500 ... Members are the basis for the organization,s international ...
... a portable scanner based on radio frequency technology, which is able ... and benign in the breast on a computer. , Using ... proven by researchers in the US, Canada and UK. However, up ... to be produced, and this had to be done in a ...
... awarded six grants totaling approximately $12 million over ... fostering a diverse scientific workforce. The initiative, called ... Promote Diversity in the Scientific Workforce, is funded ... and administered by NIH,s National Institute of General ...
... News) -- Older adults who survive severe sepsis are at ... functioning, a new study indicates. This largely invisible problem ... burden on caregivers and families, as well as increasing the ... said. Also called "blood poisoning," sepsis is a potentially ...
Cached Medicine News:Health News:Mental Health Issues Differ for U.S. Male, Female Vets 2Health News:EMBO recognizes 63 researchers for advances in life sciences 2Health News:EMBO recognizes 63 researchers for advances in life sciences 3Health News:Portable breast scanner allows cancer detection in the blink of an eye 2Health News:NIH Recovery Act grants to foster scientific workforce diversity 2Health News:Brain Deficits Higher in Seniors Who Survive Blood Poisoning 2
(Date:7/29/2015)... CAMBRIDGE, Mass. , July 29, ... ), the leader in RNA-targeted therapeutics, and Akcea ... The New England Journal of Medicine ... study evaluating volanesorsen (formerly ISIS-APOCIII Rx ) in ... This publication follows the December 2014 publication in ...
(Date:7/29/2015)...  Hologic, Inc. (NASDAQ: HOLX ) announced today ... ended June 27, 2015.  Quarterly revenues of $693.9 million ... a constant currency basis.  GAAP earnings per share (EPS) ... increased 16.2%. "Our third quarter financial results ... a company that can grow sustainably on both the ...
(Date:7/29/2015)... Inc. (Vanda) (NASDAQ: VNDA ), today announced financial ... 30, 2015. "We are impressed with U.S. ... H. Polymeropoulos M.D., Vanda,s President and CEO, "further investments ... products set the stage for the next level of ... , Total net product sales for the second quarter ...
Breaking Medicine Technology:Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 2Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 3Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 4Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 5Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 6Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 7Hologic Announces Financial Results for Third Quarter of Fiscal 2015 2Hologic Announces Financial Results for Third Quarter of Fiscal 2015 3Hologic Announces Financial Results for Third Quarter of Fiscal 2015 4Hologic Announces Financial Results for Third Quarter of Fiscal 2015 5Hologic Announces Financial Results for Third Quarter of Fiscal 2015 6Hologic Announces Financial Results for Third Quarter of Fiscal 2015 7Hologic Announces Financial Results for Third Quarter of Fiscal 2015 8Hologic Announces Financial Results for Third Quarter of Fiscal 2015 9Hologic Announces Financial Results for Third Quarter of Fiscal 2015 10Hologic Announces Financial Results for Third Quarter of Fiscal 2015 11Hologic Announces Financial Results for Third Quarter of Fiscal 2015 12Hologic Announces Financial Results for Third Quarter of Fiscal 2015 13Hologic Announces Financial Results for Third Quarter of Fiscal 2015 14Hologic Announces Financial Results for Third Quarter of Fiscal 2015 15Hologic Announces Financial Results for Third Quarter of Fiscal 2015 16Hologic Announces Financial Results for Third Quarter of Fiscal 2015 17Hologic Announces Financial Results for Third Quarter of Fiscal 2015 18Hologic Announces Financial Results for Third Quarter of Fiscal 2015 19Hologic Announces Financial Results for Third Quarter of Fiscal 2015 20Hologic Announces Financial Results for Third Quarter of Fiscal 2015 21Hologic Announces Financial Results for Third Quarter of Fiscal 2015 22Hologic Announces Financial Results for Third Quarter of Fiscal 2015 23Hologic Announces Financial Results for Third Quarter of Fiscal 2015 24Hologic Announces Financial Results for Third Quarter of Fiscal 2015 25Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 2Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 3Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 5Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 6
... Feb. 22, 2011 Proacta Incorporated and ... announced the execution of a definitive agreement ... commercialization of Proacta,s PR509, a hypoxia-activated pro-drug ... (Logo: http://photos.prnewswire.com/prnh/20110222/LA50556LOGO-a) (Logo: http://photos.prnewswire.com/prnh/20110222/LA50556LOGO-b) ...
... ResearchDx announced today the official launch of ... Recent FDA initiatives, such as the ... Paper, have spurred biopharmaceutical companies, interest in biomarker ... The traditional Contract Research Organization (CRO), which has ...
Cached Medicine Technology:Proacta Incorporated and Yakult Honsha Announce an Agreement for the Collaborative Research, Development and Commercialization for Proacta's PR509 Compound 2Proacta Incorporated and Yakult Honsha Announce an Agreement for the Collaborative Research, Development and Commercialization for Proacta's PR509 Compound 3ResearchDx Launches Contract Diagnostics Organization (CDO) 2
For newly born children 10 mm internal diameter of the cornea part. Designed to work with argon/YAG Lasers....
For use with Slitlamps which have a smaller distance between the eye and the reduction prism than the Haag-Streit 900. Designed to work with argon/YAG Lasers....
... EyeCap is a Windows-based image capture and ... colour, red-free, fluorescent and ICG Angiography images. ... and can also obtain images from any ... output. EyeCap FA has all the features ...
... EyeCap is a Windows-based image capture and ... colour, red-free, fluorescent and ICG Angiography images. ... and can also obtain images from any ... output. EyeCap RI captures high quality colour ...
Medicine Products: